Abstract
Non-invasive testing, primarily nuclear multiplanar perfusion imaging (MPI), predicts abnormal findings on coronary angiography(CATH) in 41% of patients(Patel et al NEJM 362:886-95). Due to radiation doses associated with MPI studies, concern has risen about over-utilization. In September 2010 the
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
